ストックスクリーナーアプリを入手
1.28
7.25%
-0.10
アフターアワーズ：
1.28
前日終値:
$1.38
開ける：
$1.25
24時間の取引高:
21,233
Relative Volume:
2.09
時価総額：
$12.16M
収益：
-
当期純損益:
$-2.25M
株価収益率:
-3.20
EPS:
-0.4
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-9.22%
1か月 パフォーマンス:
-20.50%
6か月 パフォーマンス:
-50.00%
1年 パフォーマンス:
+59.24%
1日の値動き範囲:
$1.25
$1.37
1週間の範囲:
$1.19
$1.50
52週間の値動き範囲:
$0.845
$4.9897
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Company Profile
XTLB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
XTLB
X T L Biopharmaceuticals Ltd Adr
|
1.28 | 12.16M | 0 | -2.25M | 0 | -0.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
479.79 | 121.85B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
698.74 | 76.83B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
624.67 | 37.96B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
246.75 | 30.69B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beone Medicines Ltd Adr
|
271.80 | 29.71B | 3.32B | -860.46M | -1.04B | -8.32 |
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2015-05-08 | 開始されました | H.C. Wainwright | Buy |
X T L Biopharmaceuticals Ltd Adr (XTLB) 最新ニュース
XTL Biopharmaceuticals Adjusts Board Representation Amid Resignations - TipRanks
XTL Biopharmaceuticals Expands Portfolio with Social Proxy Acquisition Amidst Regional Challenges - TipRanks
XTL Biopharmaceuticals Adjusts Shares, Eyes Expansion - TipRanks
XTL Biopharmaceuticals Resolves Dispute with Social Proxy - TipRanks
U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.03% - MSN
XTL Biopharmaceuticals Faces Financial Dispute After Acquisition - TipRanks
symbol__ Stock Quote Price and Forecast - CNN
XTL Biopharmaceuticals Expands with AI Company Acquisition - TipRanks
XTL Biopharmaceuticals Announces Shareholder Meeting Outcomes - TipRanks
XTL Biopharmaceuticals Acquires The Social Proxy - TipRanks
Crude Oil Dips 2%; Signet Jewelers Shares Spike Higher - Markets Insider
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection - Yahoo Finance
The Daily Biotech Pulse: Patent Win For Cellectis, Hepion Proves Efficacy In Animal Model, Job Cuts At Neon - Yahoo Finance
Benzinga's Daily Biotech Pulse: Karyopharm's STORM Study, Inogen Rallies On Earnings - Yahoo Finance
X T L Biopharmaceuticals Ltd Adr (XTLB) 財務データ
収益
当期純利益
現金流量
EPS
2.95%
0.31%
大文字化:
|
ボリューム (24 時間):